The elite of Italian oncology at the service of translational research

  • 7,6k


  • 5,1k


  • 30,2k

    Impact factor

  • 150k

    Annual hospital

  • 4,4k

    Clinical Trials (active)

ACC, the National Oncology Network founded in 2002 by the Ministry of Health, is joined by 27 Institutes for comprehensive cancer patient care and research (IRCCS), AIMaC, Italian Sarcoma Group, CNAO Foundation, INFN, INFN, Politecnico di Milano Foundation and Italian National Institute of Health, which hosts its offices.

Alliance Against Cancer has the mission to bring technological and organizational innovation from basic research to clinical practice, raising and unifying the level of care, treatment, and rehabilitation of cancer patients throughout the country.

The areas of primary interest in which ACC operates are three:

  • basic and clinical oncologic research
  • diagnosis and therapy of cancer
  • education and information in oncology

ACC has contributed to designing the telepathology and rare tumour networks, research on indexing the quality life of oncological patients, and molecular characterization of tumours.

ACC can draw on both national and international research funds and collaborate on developing clinical implementation research results (early or advanced), with the possibility of co-developing oncological drugs or diagnostic procedures.

Besides this, to promote the best oncology therapies, ACC has created the National Oncology Information Service (SION), to ensure connections between research, healthcare, and patients. A model that is now promoted by the EU and therefore, also internationally known.